Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Niraparib Combined With Radiotherapy in Patients With Recurrent Glioblastoma

NCT04715620 is registered in ClinicalTrials.gov with Tianjin Huanhu Hospital as lead sponsor.

NCT NCT04715620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04715620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Niraparib Combined With Radiotherapy in Patients With Recurrent Glioblastoma
Lead sponsor
Tianjin Huanhu Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2021
Completion date
January 31, 2023
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent glioblastoma